Status:
UNKNOWN
Overture Metabolomics Non-Selection Study
Lead Sponsor:
Overture Life
Collaborating Sponsors:
New Hope Fertility Center
Clinica Juana Crespo
Conditions:
Infertility
Eligibility:
FEMALE
18-50 years
Brief Summary
In this study, study investigators will collect embryo culture media on day 5 of vitro fertilization (IVF) culture, prior to vitrification and embryo transfer for testing via Metabolomic screening. Me...
Detailed Description
Patients will undergo ovarian stimulation, egg retrieval and fertilization of oocytes through intracytoplasmic sperm injection (ICSI). All fertilized oocytes will be cultured up to blastocyst for five...
Eligibility Criteria
Inclusion
- Women of any age, including egg donors. 50% will be \<35 and the rest 35 and older.
- Signed Subject Consent Form. No inferior limit on number of eggs
Exclusion
- At the time of initial visit:
- Require or request PGT of any kind
- Low ovarian reserve defined as follicle stimulating hormone (FSH) \>10 IU/L on day 2-4 of a prior menstrual cycle and anti-mullerian hormone (AMH) \<15 pmol/L (or \<2 ng/ml) within prior 12 months of cycle start
- At the time of embryo selection:
- Patients without at least one embryo to transfer.
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2024
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT04878991
Start Date
May 5 2021
End Date
January 30 2024
Last Update
November 14 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New Hope Fertility Center
New York, New York, United States, 10019
2
Clinical Juana Crespo
Valencia, Spain